(Q38099215)

28 August 2017

title

Ki-67 is a reliable pathological grading marker for neuroendocrine tumors (English)

1 reference

28 August 2017

Ashlie Nadler

1

1 reference

28 August 2017

Moises Cukier

2

1 reference

28 August 2017

Corwyn Rowsell

3

1 reference

28 August 2017

Sepideh Kamali

4

1 reference

28 August 2017

Yael Feinberg

5

1 reference

28 August 2017

Simron Singh

6

1 reference

28 August 2017

Calvin H L Law

7

1 reference

28 August 2017

publication date

16 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

462

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

501-505

1 reference

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Neuroendocrine tumor epidemiology: contrasting Norway and North America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

The Ki-67 protein: from the known and the unknown

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

A clinical perspective on gastric neuroendocrine neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

A simple way of quantifying immunostained cell nuclei on the whole histologic section

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-assisted image analysis procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Ki-67 labeling: a more sensitive indicator of malignant phenotype than mitotic count or tumor size?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Prognostic criteria in nonfunctioning pancreatic endocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1410-8

Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden

21 January 2018

1 reference

12 December 2020

Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors

1 reference

12 December 2020

Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

10.1007/S00428-013-1410-8

Identifiers

DOI

1 reference

28 August 2017

1 reference